Searchable abstracts of presentations at key conferences in endocrinology

ea0026p432 | Thyroid (non cancer) | ECE2011

The influence of radioiodine therapy on ophthalmologic symptoms and their relation to urine cotinine level in patients with Graves’ disease

Czarnywojtek Agata , Ruchala Marek , Czepczynski Rafal , Szczepanek Ewelina , Florek Ewa , Zamyslowska Hanna , Kulinska-Niedziela Izabela , Komar-Rychlicka Krzesislawa , Sowinski Jerzy

Introduction: Radioiodine therapy (RIT) in patients with Graves’ disease (GD) and orbitopathy (GO) is still controversial, especially in smokers, due to the risk of exacerbation of ophthalmologic symptoms.Aim: To evaluate the effect of RIT in smoking and non-smoking patients with mild GO in a 6-month follow-up.Patients and methods: We examined 26 smoking and 25 non-smoking patients, matched for age and gender, presenting hyper...

ea0041ep1073 | Thyroid (non-cancer) | ECE2016

Efficacy and safety of radioiodine therapy for mild Graves’ ophthalmopathy in dependence on nicotine consumption

Czarnywojtek Agata , Komar-Rychlicka Krzesislawa , Zgorzalewicz-Stachowiak Malgorzata , Wolinski Kosma , Stangierski Adam , Torlinska Barbara , Florek Ewa , Waligorska-Stachura Joanna , Ruchala Marek

Introduction: Graves ‘Orbitopathy (GO), is an autoimmune disease associated with Graves’ thyrotoxicosis (GT). The therapy is largely dependent on the severity and activity of ocular changes. Additionally, the severity of GO is influenced by exogenous factors, such as thyroid dysfunction, cigarette smoking or radioiodine therapy (RIT). The aim of the study was to indicate how radioiodine therapy (RIT) influences on GO in smoking and non-smoking patients.<p class="...